2021 (became Septerna) Origin Story : Septerna is co-founded by Robert Lefkowitz, a Duke University biochemist who won the 2012 Nobel Prize in Chemistry for his work decoding G protein-coupled receptors (GPCRs)
Semaglutide, known by its brand names Ozempic, Wegovy, and Rybelsus, is a revolutionary weight loss injectable peptide medication that targets the bodys glucagon-like peptide-1 receptor agonist (GLP-1)
When Increased Urination May Indicate a Problem Whilst increased urination is not a characteristic side effect of Ozempic itself, changes in urinary patterns warrant clinical attention as they may signal underlying conditions requiring investigation or management adjustments
Published in the New England Journal of Medicine, it enrolled 751 adults with obesity but without type 2 diabetes
Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) Initial FDA Approval: 2016 Side Effect Update Date: November 1, 2024 Medication Description: Treats type 2 diabetes Updated GLP-1 Drugs Side Effects/Safety Information: Warns about the serious risk of pulmonary aspiration during general anesthesia or deep sedation
